. Author manuscript; available in PMC: 2023 Oct 5.

Published in final edited form as: Diabetes Res Clin Pract. 2022 Oct 5;192:110113. doi: 10.1016/j.diabres.2022.110113

Table 3.

Regression Models for Transfer Latency association with Primary and Secondary Outcomes.

	Difference in HbAlc (%) in the first year in adult care^a	p value	IRR for ED visits in the first year in adult care^a	p value	IRR for inpatient days in the first year in adult care^a	p value

Model 1 (Unadjusted)	0.31 (0.09 to 0.53)	0.005	1.25 (1.04 to 1.51)	0.018	1.41 (1.27 to 1.58)	<0.001
Model 2 (Demographic Adjusted)^b	0.28 (0.06 to 0.50)	0.014	1.04 (0.86 to 1.27)	0.67	1.21 (1.03 to 1.28)	0.001
Model 3 (Fully Adjusted)^c	0.19 (0.04 to 0.33)	0.011	1.09 (0.90 to 1.44)	0.39	1.23 (1.11 to 1.38)	<0.001

Contrasts (i.e., mean difference in HbA1c, incidence rate ratios) are for every additional 6 months of transfer latency.

Demographic factors: gender, race, insurance type (public vs private) and age at diagnosis.

Fully adjusted model factors: demographic factors and A1c in the year prior to transition, pediatric visit frequency, last pediatric visit before or after 2010. For ED visit and hospitalization outcomes the number of these visits in the year prior to transfer was also included in the fully adjusted model.